5AM Venture Management »

Silence Therapeutics shares owned by 5AM Venture Management

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by 5AM Venture Management from 13F filings

Historical chart of 5AM Venture Management investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by 5AM Venture Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $10M 476k 21.60

More positions owned by 5AM Venture Management

Enliven Therapeutics (ELVN)
Entrada Therapeutics (TRDA)
Dianthus Therapeutics (DNTH)
Merus N V (MRUS)
Celldex Therapeutics Com New (CLDX)
Praxis Precision Medicines I Com New (PRAX)
Viking Therapeutics (VKTX)
Pharvaris N V (PHVS)
Biohaven (BHVN)
Avidity Biosciences Ord (RNA)
Tyra Biosciences (TYRA)
Vor Biopharma (VOR)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Miragen Therapeutics (VRDN)

View all positions for 5AM Venture Management

Top funds holding Silence Therapeutics

Artal Group
Lombard Odier Asset Management
Lombard Odier Asset Management
Redmile Group
Logos Global Management
Frazier Life Sciences Management
Vivo Capital
Nextech Invest
Henderson Group
Cormorant Asset Management
Adage Capital Partners GP
Aquilo Capital Management
Lynx1 Capital Management
5AM Venture Management
Millennium Management

View all funds holding Silence Therapeutics